Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis, accounting for approximately 12-24% of breast cancer cases. Accumulating evidence has indicated that there is no effective targeted therapy available for TNBC. Dipalmitoylphosphatidic acid (DPPA) is a bioactive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian-Qian, Chen, Jian, Zhou, Da-Lei, Duan, You-Fa, Qi, Cui-Ling, Li, Jiang-Chao, He, Xiao-Dong, Zhang, Min, Yang, Yong-Xia, Wang, Lijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436567/
https://www.ncbi.nlm.nih.gov/pubmed/28529455
http://dx.doi.org/10.7150/ijbs.16290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436567/
https://www.ncbi.nlm.nih.gov/pubmed/28529455
http://dx.doi.org/10.7150/ijbs.16290

Ejemplares similares